Barreiro et al. revealed that the expression of MAGOH/MAGOHB was upregulated in brain tumors, especially in glioblastoma and that the decreased expression of MAGOH/MAGOHB led to changes in the splicing spectrum [23]. Here, MAGOHB is linked to glioblastoma.